ARCHIVES

FDA Spells Out Requirement For INDs For Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 28 No. 20 | May 17, 2002

Download PDF Visit The Full Archive

Related Articles

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

January 29, 2010

Varmus’s 2016 Bypass Budget Seeks “Modest” Increase of $823 Million

December 5, 2014

DRCCA Board, Subcommittee Approve Reorganization Of Education Program

February 5, 1982

Neoadjuvant Surgery Makes Radiation Unnecessary In Some Early Breast Cancer

September 26, 2008

Cancer Advocacy: March On Washington Scheduled For September 1998

October 31, 1997

New NCI Director Plans Greater Support For Translational Research, Collaboration.

March 1, 2002